Patient Blood Management - Use and Outcome

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT02473666

Acronym

PBM-USZ

Enrollment

250000

Registered

2015-06-16

Start date

2012-01-31

Completion date

2019-12-31

Last updated

2020-11-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hemorrhage

Keywords

Patient Blood Management, Red Blood Cells, Platelet

Brief summary

Study the influence of transfusion related Patient Blood Management Program actions on transfusion-related outcome measures and cost.

Detailed description

At the University Hospital of Zurich, an in-house designed monitoring and feedback system was introduced which electronically registers each transfusion of any allogeneic blood product, be it red blood cells, plasma or platelets as well as corresponding laboratory data. Results are reported quarterly to Department heads. The investigator analyzes whether the introduction of this monitoring and feedback system as part of a patient blood management Program has a significant influence on use of allogeneic blood product transfusions and transfusion-related costs, without compromising patient outcome.

Interventions

None listed

Study design

Observational model

OTHER

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Healthy volunteers

Inclusion criteria

* Only case records, all discharged patients of the University Hospital of Zürich

Exclusion criteria

* Not discharged from our Hospital.

Design outcomes

Primary

Measure	Time frame	Description
Percentage of transfusions per participant	participants will be followed form date of hospital entry until date of discharge or date of death up to 3 years	Participant wich had transfusion will be identified and the administrative, financial and clinical data will be compared to participants without transfusions

Secondary

Measure	Time frame	Description
Percentage of transfusion of any blood product per participant	participants will be followed form date of hospital entry until date of discharge or date of death up to 3 years	Count of any blood products per case, QM Data
Cost of any blood product per participant	participants will be followed form date of hospital entry until date of discharge or date of death up to 3 years	costs per case
Survey of Patient Blood Management System	participants will be followed form date of hospital entry until date of discharge or date of death up to 3 years	clinical, financial,and administrative data of all participants will be reviewed on the focus on transfusions

Countries

Switzerland

Outcome results